Qinglong Guo Selected Research

LZ-207

1/2015

LZ-207, a Newly Synthesized Flavonoid, Induces Apoptosis and Suppresses Inflammation-Related Colon Cancer by Inhibiting the NF-κB Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qinglong Guo Research Topics

Disease

103	Neoplasms (Cancer) 01/2022 - 08/2006
29	Breast Neoplasms (Breast Cancer) 10/2020 - 08/2008
23	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2006
14	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2008
12	Hypoxia (Hypoxemia) 11/2020 - 09/2013
11	Leukemia 10/2021 - 01/2012
11	Inflammation (Inflammations) 10/2019 - 05/2009
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 08/2014
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 05/2013
8	Carcinoma (Carcinomatosis) 10/2020 - 03/2008
8	Colitis 01/2019 - 08/2013
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 08/2013
6	Colonic Neoplasms (Colon Cancer) 01/2017 - 01/2015
6	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 06/2011
5	Carcinogenesis 10/2021 - 08/2013
5	Body Weight (Weight, Body) 06/2021 - 09/2011
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 08/2008
4	Myeloid Leukemia (Leukemia, Myelocytic) 05/2022 - 11/2014
4	Glioma (Gliomas) 01/2022 - 10/2013
4	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 01/2012
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 03/2016
3	Liver Diseases (Liver Disease) 08/2020 - 08/2012
3	Colitis-Associated Neoplasms 01/2017 - 08/2013
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 11/2021
2	Infections 12/2021 - 09/2011
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2019 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 11/2018 - 06/2017
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 06/2018 - 04/2018
2	Liver Neoplasms (Liver Cancer) 01/2018 - 01/2017
2	Disease Progression 01/2018 - 08/2014
2	Stomach Neoplasms (Stomach Cancer) 01/2017 - 01/2017
2	Lung Neoplasms (Lung Cancer) 12/2016 - 03/2008
2	ST Elevation Myocardial Infarction 01/2015 - 01/2015
2	Melanoma (Melanoma, Malignant) 01/2014 - 03/2012
2	Human Influenza (Influenza) 09/2011 - 01/2010

Drug/Important Bio-Agent (IBA)

43	FlavonoidsIBA 10/2021 - 05/2009
36	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 01/2022 - 01/2009
34	wogoninIBA 05/2022 - 08/2006
18	Pharmaceutical PreparationsIBA 01/2021 - 03/2008
15	gambogic acidIBA 04/2017 - 10/2008
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2008
10	wogonosideIBA 10/2019 - 05/2009
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 06/2009
6	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 08/2006
5	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 12/2008
5	Messenger RNA (mRNA)IBA 01/2022 - 12/2011
5	baicaleinIBA 08/2020 - 01/2010
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 06/2013
5	Dextran SulfateIBA 09/2016 - 03/2015
4	Phosphotransferases (Kinase)IBA 01/2022 - 10/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2014
4	Imatinib Mesylate (Gleevec)FDA Link 09/2020 - 04/2016
4	oroxylin A-7-O-glucuronideIBA 08/2020 - 04/2016
4	InflammasomesIBA 01/2019 - 03/2015
4	PiperazineIBA 01/2018 - 01/2009
4	LYG 202IBA 01/2018 - 01/2010
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 09/2013
4	CateninsIBA 11/2016 - 10/2013
4	Matrix Metalloproteinase 2 (Gelatinase A)IBA 08/2011 - 08/2008
3	CholesterolIBA 01/2022 - 12/2011
3	Transcription Factors (Transcription Factor)IBA 11/2020 - 08/2014
3	CytokinesIBA 01/2019 - 08/2013
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2018 - 05/2015
3	LFG-500IBA 06/2017 - 01/2014
3	Biological ProductsIBA 01/2017 - 06/2009
3	Interleukin-6 (Interleukin 6)IBA 06/2016 - 08/2013
3	Annexin A5IBA 03/2014 - 11/2008
3	xanthoneIBA 11/2012 - 12/2011
2	Hormones (Hormone)IBA 01/2022 - 10/2020
2	Pyruvic Acid (Pyruvate)IBA 01/2022 - 06/2015
2	NucleotidesIBA 01/2022 - 01/2022
2	Cyclin-Dependent Kinase 9IBA 01/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2014
2	Hypoxia-Inducible Factor 1IBA 11/2020 - 06/2015
2	Histone Deacetylase InhibitorsIBA 10/2020 - 08/2020
2	GlycolipidsIBA 01/2020 - 01/2018
2	Thomsen-Friedenreich antibodiesIBA 01/2020 - 12/2019
2	artemisinin (artemisinine)IBA 11/2019 - 11/2018
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2019 - 04/2011
2	TNF Receptor-Associated Factor 2 (TRAF2)IBA 10/2019 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2018 - 03/2008
2	matrigelIBA 01/2018 - 12/2008
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2017 - 09/2016
2	NF-E2-Related Factor 2IBA 01/2017 - 11/2014
2	AzoxymethaneIBA 06/2016 - 08/2013
2	LipopolysaccharidesIBA 01/2016 - 11/2011
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 06/2015 - 09/2013
2	DNA (Deoxyribonucleic Acid)IBA 05/2015 - 11/2008
2	DAPIIBA 03/2014 - 07/2013
2	ElementsIBA 09/2013 - 12/2011
2	XanthonesIBA 11/2012 - 04/2011
1	phenylhydrazoneIBA 01/2022
1	DeferiproneIBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022

Therapy/Procedure

16	Therapeutics 01/2021 - 06/2009
5	Drug Therapy (Chemotherapy) 01/2021 - 01/2012
4	Intravenous Injections 08/2014 - 03/2008
3	Oral Administration 06/2021 - 01/2010
2	Percutaneous Coronary Intervention 01/2015 - 01/2015
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2013 - 04/2007